We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3176
Sprout Social
SPT
$701M
| $941 | ﹤0.01% |
45
+13
| +41% | +$276 |
2021 Q3
15 quarters
|
|
3177
Astronics
ATRO
$2.65B
| $937 | ﹤0.01% |
34
| – | – |
2023 Q1
9 quarters
|
|
3178
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.17B
| $934 | ﹤0.01% |
40
| – | – |
2025 Q1
1 quarter
|
|
3179
Claros Mortgage Trust
CMTG
$166M
| $932 | ﹤0.01% |
327
+242
| +285% | +$649 |
2024 Q4
2 quarters
|
|
3180
DELISTED
Day One Biopharmaceuticals
DAWN
| $923 | ﹤0.01% |
142
+138
| +3,450% | +$949 |
2024 Q4
2 quarters
|
|
3181
Arlo Technologies
ARLO
$1.34B
| $916 | ﹤0.01% |
54
-24
| -31% | -$307 |
2022 Q4
10 quarters
|
|
3182
US Diversified Real Estate ETF
PPTY
$23.8M
| $912 | ﹤0.01% |
+30
| New | +$902 |
2025 Q2
0 quarters
|
|
3183
Acadia Realty Trust
AKR
$2.54B
| $910 | ﹤0.01% |
49
-37
| -43% | -$717 |
2024 Q1
5 quarters
|
|
3184
Viridian Therapeutics
VRDN
$2.22B
| $909 | ﹤0.01% |
+65
| New | +$882 |
2025 Q2
0 quarters
|
|
3185
Acadia Pharmaceuticals
ACAD
$3.4B
| $906 | ﹤0.01% |
42
-65
| -61% | -$1.21K |
2024 Q3
3 quarters
|
|
3186
DELISTED
DIH Holdings US
DHAI
| $905 | ﹤0.01% |
148
| – | – |
2024 Q2
4 quarters
|
|
3187
Ericsson
ERIC
$34.8B
| $899 | ﹤0.01% |
106
-331
| -76% | -$2.72K |
2023 Q3
7 quarters
|
|
3188
Syndax Pharmaceuticals
SNDX
$1.22B
| $899 | ﹤0.01% |
96
-236
| -71% | -$2.6K |
2023 Q3
7 quarters
|
|
3189
BlueLinx
BXC
$576M
| $893 | ﹤0.01% |
12
-19
| -61% | -$1.33K |
2023 Q3
7 quarters
|
|
3190
DWS Municipal Income Trust
KTF
$319M
| $884 | ﹤0.01% |
100
| – | – |
2025 Q1
1 quarter
|
|
3191
One Liberty Properties
OLP
$485M
| $883 | ﹤0.01% |
37
| – | – |
2022 Q4
10 quarters
|
|
3192
Remitly
RELY
$5.22B
| $882 | ﹤0.01% |
47
+32
| +213% | +$666 |
2025 Q1
1 quarter
|
|
3193
Kymera Therapeutics
KYMR
$8.99B
| $873 | ﹤0.01% |
20
-8
| -29% | -$275 |
2023 Q4
6 quarters
|
|
3194
Pulmonx
LUNG
$79.5M
| $870 | ﹤0.01% |
336
| – | – |
2021 Q2
16 quarters
|
|
3195
Target Hospitality
TH
$1.57B
| $862 | ﹤0.01% |
121
+67
| +124% | +$465 |
2025 Q1
1 quarter
|
|
3196
First Trust Growth Strength ETF
FTGS
$1.3B
| $857 | ﹤0.01% |
+25
| New | +$785 |
2025 Q2
0 quarters
|
|
3197
Invesco Total Return Bond ETF
GTO
$2.49B
| $844 | ﹤0.01% |
18
-1,156
| -98% | -$53.6K |
2023 Q2
8 quarters
|
|
3198
Bandwidth Inc
BAND
$1.6B
| $843 | ﹤0.01% |
53
-17
| -24% | -$231 |
2020 Q2
20 quarters
|
|
3199
Oric Pharmaceuticals
ORIC
$1.32B
| $842 | ﹤0.01% |
+83
| New | +$557 |
2025 Q2
0 quarters
|
|
3200
PagerDuty
PD
$1.36B
| $840 | ﹤0.01% |
55
+35
| +175% | +$544 |
2024 Q4
2 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.